Reneo Pharmaceuticals, Inc. (RPHM)
RPHM has a market cap or net worth of $136.88 million. The enterprise value is $37.17 million.
The next earnings date is Monday, May 8, 2023, before market open.
|Estimated Earnings Date||May 8, 2023|
RPHM has 24.53 million shares outstanding. The number of shares has increased by 35.01% in one year.
|Shares Change (YoY)||+35.01%|
|Shares Change (QoQ)||+0.29%|
|Owned by Insiders (%)||3.18%|
|Owned by Institutions (%)||73.80%|
|EV / Earnings||n/a|
|EV / Sales||n/a|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 14.93, with a Debt / Equity ratio of 0.01.
|Debt / Equity||0.01|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
Return on equity (ROE) is -44.10% and return on invested capital (ROIC) is -129.60%.
|Return on Equity (ROE)||-44.10%|
|Return on Assets (ROA)||-40.90%|
|Return on Capital (ROIC)||-129.60%|
|Revenue Per Employee||n/a|
|Profits Per Employee||-$1.62M|
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has increased by +74.92% in the last 52 weeks.
|52-Week Price Change||+74.92%|
|50-Day Moving Average||3.74|
|200-Day Moving Average||3.10|
|Average Volume (30 Days)||59,291|
Short Selling Information
The latest short interest is 115,612, so 0.47% of the outstanding shares have been sold short.
|Short Previous Month||95,339|
|Short % of Shares Out||0.47%|
|Short % of Float||1.25%|
|Short Ratio (days to cover)||1.44|
|Earnings Per Share (EPS)||-$2.12|
The company has $101.17 million in cash and $1.46 million in debt, giving a net cash position of $99.71 million or $4.06 per share.
|Cash & Cash Equivalents||101.17M|
|Net Cash Per Share||$4.06|
|Equity / Book Value||99.97M|
|Book Value Per Share||4.08|
In the last 12 months, operating cash flow was -$47.36 million and capital expenditures -$346,000, giving a free cash flow of -$47.71 million.
|Operating Cash Flow||-47.36M|
|Free Cash Flow||-47.71M|
|FCF Per Share||-$1.95|
Dividends & Yields
RPHM does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
The average price target for RPHM is $25.76, which is 361.65% higher than the current price. The consensus rating is "Buy".
|Price Target Difference||361.65%|
|Revenue Growth Forecast (5Y)||n/a|
|EPS Growth Forecast (5Y)||n/a|
This stock does not have any record of stock splits.
|Last Split Date||n/a|